Early outcomes comparing induction with antithymocyte globulin vs alemtuzumab in two steroid-avoidance protocols in pediatric renal transplantation. [electronic resource]
Producer: 20210407Description: e13685 p. digitalISSN:- 1399-3046
- Adolescent
- Alemtuzumab -- therapeutic use
- Antilymphocyte Serum -- therapeutic use
- Child
- Child, Preschool
- Drug Therapy, Combination
- Female
- Graft Rejection -- prevention & control
- Humans
- Immunosuppressive Agents -- therapeutic use
- Induction Chemotherapy -- methods
- Infant
- Infant, Newborn
- Kidney Transplantation
- Male
- Steroids
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.